Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 13-Aug-24 4:17 PM View:  | Charles River Laboratories ... (CRL) | 12-Aug-24 | Gift | 2,500 | -- | -- | (1%) 237.87K to 235.37K | |
| 30-May-24 6:58 PM View: | Charles River Laboratories ... (CRL) | 29-May-24 | Payment of Exercise | 1,274 | $214.51 | $273,286.00 | (< 1%) 264.15K to 262.87K | |
| 20-Feb-24 5:28 PM View: | Charles River Laboratories ... (CRL) | 16-Feb-24 | Gift | 4,000 | -- | -- | (1%) 268.44K to 264.44K | |
| 31-Jan-24 5:03 PM View: | Charles River Laboratories ... (CRL) | 29-Jan-24 | Grant | 24,253 | -- | -- | 10% 254.95K to 279.2K | |
| 31-Jan-24 4:59 PM View: | Charles River Laboratories ... (CRL) | 29-Jan-24 | Payment of Exercise | 12,710 | $224.56 | $2,854,160.00 | (5%) 267.66K to 254.95K | |
| 31-Jan-24 5:03 PM View: | Charles River Laboratories ... (CRL) | 29-Jan-24 | Payment of Exercise | 10,757 | $220.28 | $2,369,550.00 | (4%) 279.2K to 268.44K | |
| 31-Jan-24 4:59 PM View: | Charles River Laboratories ... (CRL) | 29-Jan-24 | Option Exercise | 17,436 | $144.67 | $2,522,470.00 | 7% 250.22K to 267.66K | (9%) |
| 15-Nov-23 9:23 AM View: | Charles River Laboratories ... (CRL) | 14-Nov-23 | Purchase | 5,620 | $178.05 | $1,000,640.00 | 2% 244.6K to 250.22K | |
| 14-Aug-23 4:13 PM View: | Charles River Laboratories ... (CRL) | 10-Aug-23 | Gift | 2,500 | -- | -- | (1%) 247.1K to 244.6K | |
| 31-May-23 1:38 PM View: | Charles River Laboratories ... (CRL) | 29-May-23 | Payment of Exercise | 1,274 | $194.12 | $247,309.00 | (< 1%) 200.8K to 199.52K | |
| 17-May-23 4:55 PM View: | Charles River Laboratories ... (CRL) | 15-May-23 | Gift | 7,623 | -- | -- | (3%) 262.01K to 254.39K | |
| 22-Feb-23 4:49 PM View: | Charles River Laboratories ... (CRL) | 22-Feb-23 | Payment of Exercise | 1,814 | $243.60 | $441,890.00 | (< 1%) 257.81K to 256.0K | |
| 17-Feb-23 4:02 PM View: | Charles River Laboratories ... (CRL) | 15-Feb-23 | Private Sale (Planned) | 20,000 | $250.00 | $5,000,020.00 | (7%) 277.81K to 257.81K | |
| 31-Jan-23 5:57 PM View: | Charles River Laboratories ... (CRL) | 27-Jan-23 | Grant | 49,725 | -- | -- | 20% 249.54K to 299.26K | |
| 31-Jan-23 5:57 PM View: | Charles River Laboratories ... (CRL) | 27-Jan-23 | Payment of Exercise | 21,453 | -- | -- | (7%) 299.26K to 277.81K | |
| 31-Jan-23 5:57 PM View: | Charles River Laboratories ... (CRL) | 06-Jun-22 | Gift | 2,000 | -- | -- | (< 1%) 258.6K to 256.6K | |
| 01-Jun-22 5:17 PM View: | Charles River Laboratories ... (CRL) | 29-May-22 | Payment of Exercise | 1,311 | $244.41 | $320,422.00 | (< 1%) 250.94K to 249.63K | |
| 23-Feb-22 4:49 PM View: | Charles River Laboratories ... (CRL) | 23-Feb-22 | Payment of Exercise | 1,770 | $289.58 | $512,557.00 | (< 1%) 254.62K to 252.85K | |
| 25-Feb-22 4:20 PM View: | Charles River Laboratories ... (CRL) | 23-Feb-22 | Option Exercise | 20,296 | $109.34 | $2,219,160.00 | 8% 252.85K to 273.15K | |
| 25-Feb-22 4:20 PM View: | Charles River Laboratories ... (CRL) | 23-Feb-22 | Planned Option Sale | 20,296 | $287.83 | $5,841,870.00 | (7%) 273.15K to 252.85K | |
| 23-Feb-22 4:49 PM View: | Charles River Laboratories ... (CRL) | 22-Feb-22 | Payment of Exercise | 1,610 | $293.61 | $472,712.00 | (< 1%) 273.67K to 272.06K | |
| 23-Feb-22 4:49 PM View: | Charles River Laboratories ... (CRL) | 22-Feb-22 | Option Exercise | 17,436 | $144.67 | $2,522,470.00 | 7% 256.23K to 273.67K | (9%) |
| 23-Feb-22 4:49 PM View: | Charles River Laboratories ... (CRL) | 22-Feb-22 | Planned Option Sale | 17,436 | $288.67 | $5,033,330.00 | (6%) 272.06K to 254.62K | |
| 17-Feb-22 4:41 PM View: | Charles River Laboratories ... (CRL) | 15-Feb-22 | Private Sale (Planned) | 20,000 | $315.46 | $6,309,140.00 | (7%) 276.23K to 256.23K | |
| 01-Feb-22 5:21 PM View: | Charles River Laboratories ... (CRL) | 28-Jan-22 | Grant | 65,011 | -- | -- | 28% 236.33K to 301.34K | |
| 01-Feb-22 5:21 PM View: | Charles River Laboratories ... (CRL) | 28-Jan-22 | Payment of Exercise | 25,108 | $312.24 | $7,839,720.00 | (8%) 301.34K to 276.23K | |
| 01-Feb-22 5:21 PM View: | Charles River Laboratories ... (CRL) | 26-Oct-21 | Gift | 14,813 | -- | -- | (6%) 251.14K to 236.33K | |
| 10-Aug-21 11:42 AM View: | Charles River Laboratories ... (CRL) | 06-Aug-21 | Gift | 2,500 | -- | -- | (< 1%) 263.64K to 261.14K | |
| 10-Aug-21 11:42 AM View: | Charles River Laboratories ... (CRL) | 06-Aug-21 | Sale | 10,000 | $401.79 | $4,017,870.00 | (4%) 261.14K to 251.14K | |
| 03-Jun-21 12:48 PM View: | Charles River Laboratories ... (CRL) | 01-Jun-21 | Option Exercise | 9,577 | $179.66 | $1,720,600.00 | 4% 263.64K to 273.22K | |
| 03-Jun-21 12:48 PM View: | Charles River Laboratories ... (CRL) | 01-Jun-21 | Planned Option Sale | 9,577 | $332.23 | $3,181,750.00 | (4%) 273.22K to 263.64K | |
| 02-Jun-21 10:34 AM View: | Charles River Laboratories ... (CRL) | 29-May-21 | Payment of Exercise | 1,273 | $337.99 | $430,261.00 | (< 1%) 264.91K to 263.64K | |
| 10-May-21 5:13 PM View: | Charles River Laboratories ... (CRL) | 07-May-21 | Private Sale | 7,500 | $343.17 | $2,573,770.00 | (3%) 272.41K to 264.91K | |
| 25-Feb-21 4:23 PM View: | Charles River Laboratories ... (CRL) | 24-Feb-21 | Payment of Exercise | 2,210 | $282.98 | $625,386.00 | (< 1%) 298.63K to 296.42K | |
| 25-Feb-21 4:23 PM View: | Charles River Laboratories ... (CRL) | 24-Feb-21 | Option Exercise | 24,009 | $88.05 | $2,113,990.00 | 9% 274.62K to 298.63K | |
| 25-Feb-21 4:23 PM View: | Charles River Laboratories ... (CRL) | 24-Feb-21 | Planned Option Sale | 24,009 | $284.75 | $6,836,610.00 | (8%) 296.42K to 272.41K | |
| 24-Feb-21 11:10 AM View: | Charles River Laboratories ... (CRL) | 23-Feb-21 | Payment of Exercise | 1,994 | $283.59 | $565,478.00 | (< 1%) 296.91K to 294.92K | |
| 24-Feb-21 11:10 AM View: | Charles River Laboratories ... (CRL) | 23-Feb-21 | Option Exercise | 20,295 | $109.34 | $2,219,060.00 | 7% 276.62K to 296.91K | |
| 24-Feb-21 11:10 AM View: | Charles River Laboratories ... (CRL) | 23-Feb-21 | Planned Option Sale | 20,295 | $279.80 | $5,678,580.00 | (7%) 294.92K to 274.62K | |
| 24-Feb-21 11:10 AM View: | Charles River Laboratories ... (CRL) | 22-Feb-21 | Payment of Exercise | 1,814 | $289.55 | $525,244.00 | (< 1%) 295.87K to 294.05K | |
| 24-Feb-21 11:10 AM View: | Charles River Laboratories ... (CRL) | 22-Feb-21 | Option Exercise | 17,436 | $144.67 | $2,522,470.00 | 6% 278.43K to 295.87K | (9%) |
| 24-Feb-21 11:10 AM View: | Charles River Laboratories ... (CRL) | 22-Feb-21 | Planned Option Sale | 17,436 | $282.98 | $4,934,120.00 | (6%) 294.05K to 276.62K | |
| 16-Feb-21 11:58 AM View: | Charles River Laboratories ... (CRL) | 11-Feb-21 | Private Sale (Planned) | 30,000 | $285.02 | $8,550,560.00 | (10%) 308.43K to 278.43K | |
| 02-Feb-21 11:08 AM View: | Charles River Laboratories ... (CRL) | 29-Jan-21 | Grant | 75,129 | -- | -- | 28% 266.06K to 341.19K | |
| 02-Feb-21 11:08 AM View: | Charles River Laboratories ... (CRL) | 29-Jan-21 | Payment of Exercise | 32,753 | $260.88 | $8,544,600.00 | (10%) 341.19K to 308.43K | |
| 02-Feb-21 11:08 AM View: | Charles River Laboratories ... (CRL) | 14-Jan-21 | Gift | 3,500 | -- | -- | (1%) 269.56K to 266.06K | |
| 02-Feb-21 11:08 AM View: | Charles River Laboratories ... (CRL) | 13-Nov-20 | Gift | 4,706 | -- | -- | (2%) 274.26K to 269.56K | |
| 03-Nov-20 4:05 PM View: | Charles River Laboratories ... (CRL) | 02-Nov-20 | Sale | 22,000 | $232.38 | $5,112,270.00 | (8%) 278.83K to 256.83K | |
| 03-Nov-20 4:05 PM View: | Charles River Laboratories ... (CRL) | 07-Oct-20 | Gift | 1,000 | -- | -- | (< 1%) 279.83K to 278.83K | |
| 03-Nov-20 4:05 PM View: | Charles River Laboratories ... (CRL) | 06-Oct-20 | Gift | 1,000 | -- | -- | (< 1%) 280.83K to 279.83K |